SOX18 and breast carcinoma: Young et al. assessed the effects of disrupted SOX18 function on MCF-7 human breast cancer and human umbilical vein endothelial cell (HUVEC) proliferation by measuring BrdU incorporation and by MTT assay, cell migration using Boyden chamber assay, and capillary tube formation in vitro [44].